Transplant acceptance inducing cells (Neovii Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTransplant acceptance inducing cells (Neovii Biotech)

Drug Alias Nametransplant acceptance inducing cells (TAIC)

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsRejection of organ transplantation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNeovii Biotech Gmbh

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsRejection of organ transplantation

Inactive IndicationsN/A

ATC CodeN/A